Lv2
120 积分 2024-02-20 加入
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
10天前
已完结
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
11天前
已完结
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial
25天前
已完结
Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study
28天前
已完结
A Novel Algorithm for Streamlining Diagnosis of Advanced Liver Fibrosis in CHB Patients with Concurrent Hepatic Steatosis
28天前
已完结
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study
1个月前
已完结
[NAFLD renaming to MAFLD, MASLD: background, similarities, differences, and countermeasures]
2个月前
已完结
Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD‐related liver fibrosis
2个月前
已完结
皖公网安备34019202002308
